Catalyst Wire Dossier Catalyst Wire Dossier

olmesartan and hydrochlorothiazide

· Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for olmesartan and hydrochlorothiazide, covering 2009-06-17 to 2009-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Phase 3]

See pricing